RxPG News Feed for RxPG News

Medical Research Health Special Topics World
  Home
 
   Health
 Aging
 Asian Health
 Events
 Fitness
 Food & Nutrition
 Happiness
 Men's Health
 Mental Health
 Occupational Health
 Parenting
 Public Health
 Sleep Hygiene
 Women's Health
 
   Healthcare
 Africa
 Australia
 Canada Healthcare
 China Healthcare
 India Healthcare
 New Zealand
 South Africa
 UK
 USA
 World Healthcare
 
   Latest Research
 Aging
 Alternative Medicine
 Anaethesia
 Biochemistry
 Biotechnology
 Cancer
 Cardiology
 Clinical Trials
 Cytology
 Dental
 Dermatology
 Embryology
 Endocrinology
 ENT
 Environment
 Epidemiology
 Gastroenterology
  Constipation
  GERD
  IBS
  Inflammatory Bowel Disease
  Liver
 Genetics
 Gynaecology
 Haematology
 Immunology
 Infectious Diseases
 Medicine
 Metabolism
 Microbiology
 Musculoskeletal
 Nephrology
 Neurosciences
 Obstetrics
 Ophthalmology
 Orthopedics
 Paediatrics
 Pathology
 Pharmacology
 Physiology
 Physiotherapy
 Psychiatry
 Radiology
 Rheumatology
 Sports Medicine
 Surgery
 Toxicology
 Urology
 
   Medical News
 Awards & Prizes
 Epidemics
 Launch
 Opinion
 Professionals
 
   Special Topics
 Ethics
 Euthanasia
 Evolution
 Feature
 Odd Medical News
 Climate

Last Updated: Oct 11, 2012 - 10:22:56 PM
Gastroenterology Channel

subscribe to Gastroenterology newsletter
Latest Research : Gastroenterology

   EMAIL   |   PRINT
Cholesterol regulating Liver X Receptors (LXR) maintain Fat Levels

Apr 13, 2005 - 8:01:00 PM
“In the animals lacking LXR, not only can they not store fat, but their cholesterol concentrations build to excessive levels, which somehow drives the animals to burn fat. There is some cholesterol-related signal that the liver sends out that permits fat-burning to happen, and uncovering that signal is the big mystery we’re trying to solve next, which may have therapeutic applications.”

 
[RxPG] A protein that regulates cholesterol levels in the body also is responsible for maintaining a healthy balance between fat storage and fat burning, according to a UT Southwestern Medical Center study that may lead to new drug targets in the fight against obesity.

In animals and humans, a protein called the liver X receptor, or LXR, senses cholesterol levels. When these receptors detect rising amounts of cholesterol, they activate genes and a series of biochemical reactions that remove diet-derived cholesterol from the body.

The cholesterol-regulating role of LXRs is well understood, but until now, their role in regulating fat levels was unclear.

In their recent study, UT Southwestern researchers found that “knockout” mice genetically engineered to lack the gene for LXR could not store fat and did not become obese when they were fed a Western-style diet high in both fat and cholesterol. However, knockout mice fed only fat were able to store fat.

High-fat diets typically contain both fat and cholesterol, but this study shows that it is the cholesterol component of a high-fat diet that actually triggers the normal fat-storage process in the body, said Dr. David Mangelsdorf, professor of pharmacology and biochemistry at UT Southwestern and senior author of the study.

“Our studies suggest a dual role for LXRs,” said Dr. Mangelsdorf, an investigator in the Howard Hughes Medical Institute at UT Southwestern. “Not only do these receptors sense and limit the accumulation of dietary cholesterol, but their activation by cholesterol is required to initiate a major fat-storing process.”

Because the knockout mice cannot remove excess dietary cholesterol, the animals develop extremely high cholesterol levels.

Surprisingly, the researchers found that the buildup of cholesterol in the knockout mice actually activates a fat-burning process, a finding that provided more evidence of the role LXR plays in regulating the balance between fat burning and fat storage.

“In the animals lacking LXR, not only can they not store fat, but their cholesterol concentrations build to excessive levels, which somehow drives the animals to burn fat,” said Dr. Mangelsdorf, who holds the Doris and Bryan Wildenthal Distinguished Chair in Medical Science. “There is some cholesterol-related signal that the liver sends out that permits fat-burning to happen, and uncovering that signal is the big mystery we’re trying to solve next, which may have therapeutic applications.”

A better understanding of the cholesterol-driven, fat-burning signal may lead to drugs that control the signal and boost the body’s ability to burn unwanted fat instead of storing it, Dr. Mangelsdorf said. The research also may aid in the development of cholesterol-related drugs. High levels of low-density lipoproteins, or “bad” cholesterol, in humans is a major risk factor for heart disease, heart attack and stroke because it contributes to the buildup of plaque that clogs the walls of arteries.

Previous studies have pointed to a protein called SREBP-1c as the primary component in the biochemical pathway that regulates fat metabolism. When an animal eats a meal rich in nutrients, insulin levels in its body go up. Insulin signals to the SREBP-1c protein to activate subsequent components of the pathway, allowing the body to store incoming nutrients as fat.

But Dr. Mangelsdorf’s research group has shown that LXRs actually regulate SREBP-1c, activating the gene responsible for making the SREBP-1c protein in the first place. “LXR, this cholesterol sensor, is required for SREBP-1c to be expressed, to get SREBP-1c to initiate its role in regulating fat storage,” said Dr. Mangelsdorf, who discovered the LXR protein and the gene responsible for making it. “SREBP-1c had been considered the master regulator of fat synthesis, but our studies have shown that LXR is the master regulator of the master regulator.”

From the point of view of evolution, an animal capable of linking its ability to sense cholesterol with its ability to store fat may have had a survival advantage. An adult mammal has virtually no need for dietary cholesterol because its body can synthesize enough on its own. But LXRs give an animal the ability to sense the cholesterol component of a high-fat diet and get rid of it, while retaining the fat and storing it for times of deprivation.

“Our work suggests that fat storage is inextricably linked to the body’s ability to metabolize cholesterol and that the LXRs have evolved as the sensors that govern the unique cross talk between these two important metabolic pathways,” Dr. Mangelsdorf said.



Publication: The research appears in the April issue of the journal Cell Metabolism.
On the web: www.utsouthwestern.edu 

Advertise in this space for $10 per month. Contact us today.


Related Gastroenterology News
4 UCLA stem cell researchers receive CIRM Early Translational grants
Genetics defines a distinct liver disease
Nerve damage may underlie widespread, unexplained chronic pain in children
Colonoscopy cost sharing eliminated for privately insured patients
EASL publishes first comprehensive literature review on the burden of liver disease in Europe
Targeting neurotransmitter may help treat gastrointestinal conditions
NIH launches free database of drugs associated with liver injury
Genetic clues to the causes of primary biliary cirrhosis!
Taxman Foundation pledges $2.5 million to boost training of digestive disease experts
Early introduction of biologic therapy improves Crohn's disease outcomes

Subscribe to Gastroenterology Newsletter

Enter your email address:


 Additional information about the news article
Other UT Southwestern researchers involved in the study were Dr. Nada Kalaany, postdoctoral researcher in pharmacology; Dr. Karine Gauthier former postdoctoral fellow; Dr. Pradeep Mammen, assistant professor of internal medicine; Dr. Tatsuya Kitazume, biochemistry postdoctoral researcher; Dr. Julian Peterson, professor of biochemistry; Dr. Jay Horton, associate professor of internal medicine and molecular genetics; and Dr. Daniel Garry, associate professor of internal medicine and molecular biology. Researchers at Harvard Medical School also participated. The work was funded by the Howard Hughes Medical Institute, the Robert A. Welch Foundation and the National Institutes of Health.
 Feedback
For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 
Contact us

RxPG Online

Nerve

 

    Full Text RSS

© All rights reserved by RxPG Medical Solutions Private Limited (India)